Comment From the Editor in Chief
Brian J. Oldfield
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsNutrition, Genetics, and Disease · Pharmacology and Obesity Treatment · Diet and metabolism studies
The Journal is proud to highlight a “Special Issue on the Personalised Management of Obesity,” spearheaded by the BETTER4U Consortium, which has been funded in this regard by the EU.
While there is little doubt that personalized medicine is an aspirational cornerstone of effective prevention, treatment, and ongoing management of obesity, what has been lacking is a cogent and cohesive roadmap toward that endpoint.
It is hoped that the series of papers published in Obesity Reviews over coming months under this banner will elucidate the potential of this personalized approach and the course that needs to be followed to achieve it.
I hope that our readership will appreciate the insights derived from this series of papers as much as I have in helping to review them.
Regards
Prof Brian J. Oldfield, PhD,Editor in Chief,Obesity Reviews
Funding
The author has nothing to report.